Community DVT Service. Phase 1: Patient visits their Registered GP/Out of Hours Provider

Size: px
Start display at page:

Download "Community DVT Service. Phase 1: Patient visits their Registered GP/Out of Hours Provider"

Transcription

1 Community DVT Service Quick Reference Guide Phase 1 and 2 Before referring a patient to the GP Care DVT Pathway please familiarise yourself with the Exclusion Criteria to help reduce the number of inappropriate referrals made to the Community DVT Service. Phase 1: Patient visits their Registered GP/Out of Hours Provider Where Patient presents with potential DVT: Registered GP/Out of Hours GP ( GP ) prepares Patient Record Card (electronic version available for auto completion of Patient details); GP performs Wells Score; Wells Criteria: Present Score Lower limb trauma or surgery or immobilisation in a plaster cast +1 Bedridden for more than three days or surgery within the last four weeks +1 Tenderness along line of femoral or popliteal veins +1 Entire limb swollen +1 Calf more than 3cm bigger circumference compared to other limb +1 Pitting oedema +1 Dilated collateral superficial veins (non-varicose) +1 Malignancy (including treatment up to six months previously) +1 Previous DVT +1 Alternative diagnosis more likely than DVT -2 Clinical probability of DVT with score >2 High 1-2 Moderate <1 Low GP performs D-dimer test using Near Patient Testing Kit where: Wells Score < 1 but high clinical suspicion; or Wells Score >/= 1. Select appropriate instruction dependent upon preferred D-Dimer Testing Kit used; CLEARTEST D-dimer test: Tear open foil pouch and place the test device on a clean and level surface. Note: o Best results will be obtained if the test is performed immediately after opening the foil pouch Take finger prick blood sample: o Wash the patient s hand with soap and warm water or clean with an alcohol swab. Allow to dry. o Massage the hand without touching the puncture site by rubbing down the hand towards the fingertip of the middle or ring finger. o Puncture the skin with a sterile lancet. Wipe away the first sign of blood. o Gently rub the hand from wrist to palm to finger to form a rounded drop of blood over the puncture site. o Note venous sample can be taken as alternative if necessary Using the pipette supplied, hold the pipette horizontally and draw up sufficient blood for the test. Allow 2 hanging drops of fingerstick whole blood specimen (approximately 40 µl) to fall into the centre of the specimen well of the test device. Immediately add 1 drop of buffer solution to the specimen well and start the timer. Leave the test device lying horizontal and wait for the coloured line(s) to appear. Read results at 10 minutes (although positive results can often be seen much earlier than this) Do not interpret results after more than 15 minutes. Author : NC/PN Page 1 of 5 June 2012

2 CLEARVIEW D-dimer test: Tear open foil pouch and place the test device on a flat horizontal surface. Note: o Once pouch is opened, commence use of the device within 10 minutes o Test and PC (Patient Control) zones are dyed yellow for manufacturing quality control purposes; the dye does not interfere with the test results Take finger prick blood sample: o Lance patient s finger using sterile lancing device (min depth 1.8mm) o Using the capillary pipette provided collect finger prick blood sample (Do not use the venous pipettes.) Hold a capillary pipette horizontally and touch the tip to the blood drop on the patient s finger Do not squeeze the bulb of the pipette during sampling or obstruct the vent; capillary action will automatically draw the blood into the pipette Allow the pipette to fill to the black line o Note venous sample can be taken as alternative if necessary Immediately dispense all of the blood (35ul) from the capillary pipette into the round sample well of the test device o Hold the capillary pipette in a vertical position above the round sample well o Place a finger over the vent hole in the capillary pipette and dispense all of the blood into the well Allow the blood sample to completely penetrate the sample pad before adding 2 drops of the buffer solution Leave the test device lying horizontal and read the result at 10 minutes (although positive results can often be seen much earlier than this) Further instruction including diagrams is available at If D-dimer is negative, and ultrasound is not required, then GP completes sections 1a and 2a of Patient Record Card and faxes to GP Care on The clinical diagnosis should not be based on the result of the D-dimer test alone. The full clinical context of the patient must be included when making a diagnostic decision taking into account the clinical signs and other relevant information such as the Wells pre-test probability score or equivalent. Therefore the D-dimer must not be used as a stand alone test. If D-dimer is positive, or the GP has a high clinical suspicion of the presence of DVT, then GP: o Explains implications of DVT to Patient and that it is only a potential DVT at this stage; o Calculates appropriate Clexane dosage (1.5mg per 1kg of body weight) and administers to Patient (see table on following page). Author : NC/PN Page 2 of 5 June 2012

3 (Treatment of DVT by subcutaneous injection of Clexane, 1.5mg/kg (150units/kg) every 24 hours for at least 5 days (or until excluded or adequate oral anticoagulation established)) CLEXANE DOSES Weight (kg) Dose (mg) Size of vial Vol (ml) unit/ml 100 units or under dose required volume/ After 100 units ie 67kgs weight = volume/ CLEXANE DOSES Weight (kg) Dose (mg) Size of vial Vol (ml) unit/ml After 150 units ie 103kgs weight = volume/ x x x x x x x x x x The GP then: o Books a same or next working day Ultrasound Appointment by calling GP Care on (office hours) and informs the Patient of Ultrasound Appointment time and location; NB: If the Patient Appointment is after hours and there is no answer at GP Care then the GP advises the patient that GP Care will telephone the patient as soon as possible on the next working day and ensures the telephone number that the patient will be contactable on is written on the Patient Record Card; o Completes sections 1a, 1b, 2a, 2b and 3 of Patient Record Card, immediately faxes to GP Care on and gives original to Patient to take to the Ultrasound Appointment. NB: If Patient has to wait over a weekend for an Ultrasound Appointment then the GP refers the Patient to attend Frendoc on each day over the weekend to receive further Clexane injections pending the Ultrasound Scan. The referral should be made by faxing the Patient Record Card to Frendoc on ; a copy is also faxed to GP Care. The patient should be advised to telephone Frendoc after 08.00am on Saturday to arrange a same day appointment on (the telephone number is printed on the Frendoc map). Author : NC/PN Page 3 of 5 June 2012

4 Phase 2: Ultrasound Scan The Patient attends the GP Care Ultrasound Clinic at Christchurch (Downend), West Walk (Yate), Almondsbury Surgery or Greenway Community Practice (Southmead), staffed by GP Care s team of ultrasonographers. If Ultrasound Scan is negative Patient is discharged back to the Registered GP by the relevant GP Care Ultrasound Clinic; and the GP is notified of the scan result by fax; If Ultrasound Scan is positive: o Patient is immediately transferred to the Duty Doctor at the Treatment Centre where they have been scanned; o Registered GP is notified of positive Scan result by fax. NB: Following day 1 of anticoagulation, patients can attend an alternative DVT Treatment Centre if they wish but have to attend that centre for the remainder of the anticoagulation course. As well as the four Treatment Centres listed above, patients can also choose to be treated at Seymour Medical Centre in Easton, from Day 2 onwards. Phase 3: Anticoagulation at DVT Treatment Centres Refer to separate Guide to Anticoagulation Pulmonary Embolism If at any point during the pathway a Pulmonary Embolism is suspected, the Duty Doctor should contact the patient s registered GP and ascertain consent to refer the patient directly to secondary care. The clinicians at secondary care will assess whether the patient is suitable for community anticoagulation; if this is deemed the case GP Care will accept the patient back onto the pathway at the centre of patient s choice. DNAs Procedures to minimise risk of DNAs are as follows: If at any point a Patient does not attend an anticoagulation appointment then the DVT Treatment Centre should endeavour to make contact with the Patient by phone; If no contact has been possible within 24 hours of the appointment time the DVT Treatment Centre should send a Chasing Patient Letter using the pro forma letter in the Blue DVT File and notify GP Care and inform the Patient s Registered GP that the Patient is being discharged back to the Registered GP; Responsibility for the Patient then reverts to the Patient s Registered GP. House-bound Patients requiring transport The Service is available only to Patients who can attend a DVT treatment centre for an Ultrasound Scan and follow-up anticoagulation. Patients not able to use Warfarin The Service is available only to Patients who can use Warfarin. Payments by GP Care to Performers GP Care will pay Performers according to the work performed as documented on the Patient Record Card. Consumables (D-dimer tests, Clexane and Coaguchek testing strips will also be reimbursed by GP Care on a usage basis); Payments will be made on a calendar month basis in respect of work performed for Patients whose Pathways were completed in that calendar month; An electronic pro-forma invoice detailing services provided and amounts due to the Performer will be supplied by GP Care at the end of each month. Once agreed, the Performer should print the invoice on their headed notepaper and forward it to GP Care for payment. NB: It is critical that Patient Record Cards (including those for Negative D-dimer tests) are completed on an accurate and timely basis and forwarded to GP Care in order that Performers are remunerated correctly. Author : NC/PN Page 4 of 5 June 2012

5 Inclusion Criteria Aged 18 years and over Prior to Doppler Ultrasound: Patients assessed to be at significant risk of DVT based on a clinical assessment and examination by a qualified medical practitioner together with Wells scoring and a D-dimer test if appropriate. Following a positive Doppler Ultrasound scan: Patients who have a deep vein thrombosis proven on scan and who require treatment to prevent complication of the thrombosis. Exclusion Criteria Age less than 18 years Housebound patients Visiting patients (i.e. Non South Gloucestershire PCT patients) Absolute Contra indications: (Please seek guidance from a consultant physician prior to referring patients with any of the following conditions to the Community DVT Service) Pulmonary Embolism or suggestion thereof (including dyspnoea or chest pain+ unilateral leg swelling) Potential bleeding lesions Active Peptic Ulcer, oesophageal varices, aneurysm and proliferative retinopathy Recent Organ biopsy Recent Trauma or Surgery to the head, orbit or spine Recent stroke or transient ischaemic attack Confirmed intracranial or intraspinal bleed or following surgery to the eye or central nervous system (within 1 month) Infective Endocarditis History of heparin induced thrombocytopenia or thrombosis Homozygous protein C deficiency (risk of skin necrosis) Other disease process that requires admission Axillary Vein DVT Positive DVT but contraindication to anticoagulation Patients with complications that prevent use of Warfarin Pregnant women and breast feeding mothers Hypersensitivity to enoxaparin sodium, Heparin or its derivatives including other low molecular weight heparins. Relative Contraindications Past history of gastrointestinal bleeding Liver disease/liver damage Renal failure Alcoholism Mental Impairment Thrombocytopenia Coagulation disorders Interacting Drugs, in particular non steroidal anti-inflammatory drugs, Clopidogrel and glucocorticoids Poor attendance for regular blood tests or commitment to treatment. Uncontrolled hypertension Recent surgery (within 1 month) other than for minor conditions Social circumstances which may prevent community based treatment Pain inadequately controlled Mentally unstable or uncooperative patient. Proliferative diabetic retinopathy. Should a patient exhibit any of the above exclusions, at any stage during the Service Pathway, the Treatment Centre Duty Doctor should liaise with the patient s registered GP to agree the most suitable means of treatment. Author : NC/PN Page 5 of 5 June 2012

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range

Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspected Deep Vein Thrombosis (DVT) Pathway for Non Pregnant patients Updated November 2016, with new D-dimer reference range Suspect a DVT? Complete a Two-level DVT Wells score on ICE system (see page

More information

Patient Information. Preventing and treating blood clots

Patient Information. Preventing and treating blood clots Patient Information Preventing and treating blood clots 1_Clexane_Patient_Booklet_AW05.indd 1 8/04/2016 11:26 a The information provided in this document is for patients prescribed CLEXANE, and should

More information

Suspected Deep Vein Thrombosis (DVT) Assessment

Suspected Deep Vein Thrombosis (DVT) Assessment CHI no... First name... DOB... /... /... Last name... Sex: c M c F Address...... Telephone... or attach addressograph label here Hospital/Location: c Hairmyres c Monklands c Wishaw Other (specify)... Ward/Base...

More information

DVT - initial management NSCCG

DVT - initial management NSCCG Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis

More information

CoaguChek S System. Quick Reference Guide. This is a CLIA-waived System. Coagulation Testing with Fresh Whole Blood

CoaguChek S System. Quick Reference Guide. This is a CLIA-waived System. Coagulation Testing with Fresh Whole Blood CoaguChek S System This is a CLIA-waived System Quick Reference Guide Coagulation Testing with Fresh Whole Blood May not print or view at 100% All unmarked prints black. Coag Swoosh prints gradients of

More information

ONE-STEP WHOLE BLOOD H.PYLORI TEST. Product Code: 24529

ONE-STEP WHOLE BLOOD H.PYLORI TEST. Product Code: 24529 ONE-STEP WHOLE BLOOD H.PYLORI TEST Product Code: 24529 Contents of Package: - Foil Package (Contains: Test Device and Dropper) - Vial of Test Solution - Finger Stick Device Alcohol Swab Materials required

More information

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Version 5.2 Version: 5.2 Authorised by: Joint Medicines

More information

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE PRINCIPLE: The Determine HIV-1/2 Ag/Ag Combo assay is a qualitative immunoassay for the simultaneous detection of Human Immunodeficiency

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

The role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes

The role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes The role of continuous glucose monitoring as a self-monitoring behaviour change tool to enhance glycaemic control in individuals with type 2 diabetes You have been fitted with a Guardian Connect continuous

More information

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS Unigold Recombigen HIV 1/2 Training for HIV Testing Sites Updated: February 2018 Cicely Richard Office of HIV/AIDS Updated: February 2018 Cicely Richard Office of HIV/AIDS UNIGOLD RECOMBIGEN HIV 1/2 TRAINING

More information

CLINICAL GUIDELINES ID TAG

CLINICAL GUIDELINES ID TAG Title: Author: Speciality/ Division: Directorate: Date Uploaded: Review Date: September 2019 CG ID TAG CG0423 CLINICAL GUIDELINES ID TAG Clinical Guideline for Alteplase in intra-arterial thrombolysis

More information

Venous Thromboembolism (VTE)

Venous Thromboembolism (VTE) Venous Thromboembolism (VTE) Nursing A guide for patients and carers Contents Why do blood clots form in veins?... 1 How common is a deep vein thrombosis (DVT) or pulmonary embolus (PE)?... 2 How are DVTs/

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,

More information

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test Complexity: WAIVED for fingerstick whole blood and venipuncture whole blood. A Certificate of CLIA Waiver is required to perform the test

More information

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT) Page 1 of 11 Venous Thromboembolism () What is a clot or Venous Thromboembolism ()? Blood clots are called Venous Thromboembolism (). There are 2 main types: is a clot in a deep vein, usually an arm or

More information

Good to know. Tips and tricks for accurate blood glucose monitoring

Good to know. Tips and tricks for accurate blood glucose monitoring Good to know Tips and tricks for accurate blood glucose monitoring Tip 1 Washing your hands No place for dirt Accurate blood glucose readings are essential for your diabetes care. Correct self-testing

More information

Preventing Blood Clots in Adult Patients

Preventing Blood Clots in Adult Patients Manchester Royal Eye Hospital Surgical Services Information for Patients Preventing Blood Clots in Adult Patients This leaflet will give you information on how to reduce the risk of developing blood clots

More information

Skills workshop: Screening tests for syphilis

Skills workshop: Screening tests for syphilis 1D Skills workshop: Screening tests for syphilis Objectives When you have completed this skills workshop you should be able to: Screen a patient for syphilis with the syphilis rapid test and the RPR card

More information

Pathology Service User Guide Haematology

Pathology Service User Guide Haematology Pathology Service User Guide Haematology St Richard s This section of the Pathology Service User Guide includes: Anticoagulant Therapy Information about the Anticoagulant Clinic Low Molecular Weight Heparin

More information

Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin

Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin Treatment of deep vein thrombosis and pulmonary embolism with low molecular weight heparin You have been given this leaflet because you have a blood clot. Normally blood flows freely around the body without

More information

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting

Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting ANTICOAGULANT SERVICE Guidelines for slow loading of patients on warfarin for Atrial Fibrillation (AF) in the non acute setting Introduction Fast loading of warfarin carries a risk of over anticoagulation

More information

To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status.

To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status. Module 9 Performing HIV Rapid Tests Purpose To provide you with necessary knowledge and skills to accurately perform 3 HIV rapid tests and to determine HIV status. Pre-requisite Modules Module 3: Overview

More information

PE Pathway. The charts are listed as follows:

PE Pathway. The charts are listed as follows: PE Pathway This document comprises 6 simple flow charts to assist clinicians in the investigation and treatment of suspected or confirmed Acute Pulmonary Emboli. The pathway has been put together using

More information

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust MANAGEMENT OF PATIENTS WITH DEEP VEIN THROMBOSIS (DVT) IN THE COMMUNITY SETTING & ANTICOAGULATION CLINICS THE PAST, PRESENT AND THE FUTURE Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital

More information

Point of Care Testing for INR using CoaguChek XS Plus

Point of Care Testing for INR using CoaguChek XS Plus Point of Care Testing, Pathology Page 1 of 18 Point of Care Testing for INR using CoaguChek XS Plus EDITION No 1.4 DATE OF ISSUE Feb 2014 REVIEW INTERVAL AUTHOR LOCATION OF COPIES 3 YEARS D O Neill 1.

More information

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1 The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS

More information

CHAPTER 2 VENOUS THROMBOEMBOLISM

CHAPTER 2 VENOUS THROMBOEMBOLISM CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology

More information

Local steroid injections to joints and soft tissues

Local steroid injections to joints and soft tissues Local steroid injections to joints and soft tissues Pain Management Team Patient Information Leaflet Introduction This leaflet will provide you with information about what to expect when you come in for

More information

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set

ST Elevation Myocardial Infarction (STEMI) Reperfusion Order Set Form Title Form Number CH-0454 2018, Alberta Health Services, CKCM This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. The license does not

More information

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein

More information

DVT Primary Care Prescribing Pathway

DVT Primary Care Prescribing Pathway DVT Primary Care Prescribing Pathway Scope Classification Author Health Economy Wide Guideline East Lancashire Medicines Management Board (Reviewed December 207) Authorised by ELMMB Date February 208 Reviewed

More information

Items in the package:

Items in the package: Intended Use: The EasyLife Hb Monitoring System is designed for in vitro diagnostic use only (external use only), and is suitable for self-testing. The system is for healthcare professionals and persons

More information

Specimen Collection Policies

Specimen Collection Policies Specimen Collection Policies Purpose Great River Medical Center Laboratory is a hospital-based and outreach laboratory with specific standards of excellence. To best serve our patients, all specimens will

More information

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer

More information

MDT2. Self-Monitoring Blood Glucose System. Quick Reference Guide

MDT2. Self-Monitoring Blood Glucose System. Quick Reference Guide MDT2 Self-Monitoring Blood Glucose System Quick Reference Guide Inserting Batteries 1. Open the battery door on the back of the meter by pushing the tab in the direction of the arrow. 2. Insert two batteries.

More information

1.0 PATIENT CARE Including Physical Healthcare

1.0 PATIENT CARE Including Physical Healthcare SECTION: 1.0 PATIENT CARE Including Physical Healthcare POLICY /PROCEDURE: 1.33 NATURE AND SCOPE: SUBJECT: PROCEDURE - TRUST WIDE VENOUS THROMBOEMBOLISM (VTE) This procedure details Venous Thromboembolism

More information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur

More information

USO PROFESSIONALE PROFESSIONAL USE

USO PROFESSIONALE PROFESSIONAL USE Gima S.p.A. - Via Marconi, 1-20060 Gessate (MI) Italy Italia: tel. 199 400 401 - fax 199 400 403 Export: tel. +39 02 953854209/221/225 fax +39 02 95380056 gima@gimaitaly.com - export@gimaitaly.com www.gimaitaly.com

More information

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers Thrombosis and Anticoagulation Team Warfarin Information for patients, relatives and carers What is warfarin? Warfarin is an anticoagulant. Anticoagulants are drugs which prevent harmful blood clots forming

More information

EME. Self-Monitoring Blood Glucose System. Quick Reference Guide

EME. Self-Monitoring Blood Glucose System. Quick Reference Guide EME Self-Monitoring Blood Glucose System Quick Reference Guide Inserting Batteries 1. Open the battery door on the back of the meter by pushing the tab in the direction of the arrow and pulling the door

More information

QUICK REFERENCE INSTRUCTIONS. THYROCHEK TSH Cassette

QUICK REFERENCE INSTRUCTIONS. THYROCHEK TSH Cassette QUICK REFERENCE INSTRUCTIONS THYROCHEK TSH Cassette A certificate of CLIA waiver is required to perform the testing in a waived setting. If the laboratory does not have a Certificate of Waiver, the Application

More information

Standard Operating Procedure for. the Safe Administration of Dalteparin (Fragmin), Tinzaparin (Innohep) and Enoxaparin (Clexane) in the Community

Standard Operating Procedure for. the Safe Administration of Dalteparin (Fragmin), Tinzaparin (Innohep) and Enoxaparin (Clexane) in the Community Standard Operating Procedure for the Safe Administration of Dalteparin (Fragmin), Tinzaparin (Innohep) and Enoxaparin (Clexane) in the Community DOCUMENT CONTROL: Version: 2. Ratified by: Quality Assurance

More information

INTRODUCTION Indication and Licensing

INTRODUCTION Indication and Licensing City and Hackney Clinical Commissioning Group Homerton University Hospital Foundation Trust DRUG NAME: Apixaban (Eliquis ) Transfer of Care document Indication: Treatment of acute venous thromboembolism

More information

Dear HighQ Check System Owner :

Dear HighQ Check System Owner : Dear HighQ Check System Owner : Thank you for purchasing the HighQ Check Blood Glucose Monitoring System. This manual provides important information to help you to use the system properly. Before using

More information

RADIOFREQUENCY ABLATION. Professor M Baguneid MB ChB MD FRCS

RADIOFREQUENCY ABLATION. Professor M Baguneid MB ChB MD FRCS RADIOFREQUENCY ABLATION This minimally invasive treatment involves closing the faulty veins using a keyhole approach thereby avoiding the larger cuts and avoiding stripping of the veins. Professor M Baguneid

More information

Alere INRatio 2 METHOD AND SAMPLE COLLECTION

Alere INRatio 2 METHOD AND SAMPLE COLLECTION Alere INRatio 2 METHOD AND SAMPLE COLLECTION 1. PURPOSE AND SCOPE The purpose of this document is to describe the procedure for performing an INR test using the Alere INRatio2 analyser. The INRatio2 meter

More information

North East Essex Medicines Management Committee

North East Essex Medicines Management Committee Colchester Hospital University NHS Foundation Trust North East Essex Clinical Commissioning Group North East Essex Medicines Management Committee ORAL ANTICOAGULANT (Vit K antagonist only) MANAGEMENT GUIDELINES

More information

Appendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES. CP Direct Vision Sclerotherapy Clinical procedure

Appendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES. CP Direct Vision Sclerotherapy Clinical procedure Appendix 1 to Direct Vision Sclerotherapy AUSTRALASIAN COLLEGE OF PHLEBOLOGY CLINICAL PROCEDURES CP Direct Vision Sclerotherapy Clinical procedure 1 PURPOSE This procedure summarises the actions required

More information

I can show you how to check my child s blood sugar

I can show you how to check my child s blood sugar Our Journey with Diabetes Si usted desea esta información en español, por favor pídasela a su enfermero o doctor. I can show you how to check my child s blood sugar Testing Blood Sugar Blood sugar levels

More information

BLOOD COLLECTION GUIDELINES

BLOOD COLLECTION GUIDELINES I. Patient Identification Lee Memorial Health System Lee County, FL CLINICAL LABORATORY BLOOD COLLECTION GUIDELINES A. Inpatient / Outpatient with armband 1. When possible, ask patient to state their name

More information

P-RMS: LT/H/PSUR/0004/001

P-RMS: LT/H/PSUR/0004/001 Core Safety Profile Active substance: Dalteparine Pharmaceutical form(s)/strength: Solution for injection, 2500 I.U./0.2ml, 2500 I.U./ml, 5000 I.U./0.2ml, 7500 I.U./0.3ml, 7500 I.U./0.75ml, 10000 I.U./0.4ml,

More information

Venous Thromboembolism (VTE) A guide for patients with cancer

Venous Thromboembolism (VTE) A guide for patients with cancer Cancer Patient InformationPtient Education Inform Venous Thromboembolism (VTE) A guide for patients with cancer Table of Contents Venous Thromboembolism (VTE)... 3 Deep Vein Thrombosis (DVT) and Pulmonary

More information

I know my value CoaguChek XS Pro system

I know my value CoaguChek XS Pro system I know my value CoaguChek XS Pro system The smart way to manage your anticoagulation clinic CoaguChek XS Pro system A barcode scanner can make a difference There has been an extraordinary increase in the

More information

Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF

Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF Edoxaban for the treatment and prevention of venous thromboembolism (DVT or PE) or stroke prevention in non-valvular AF Traffic light classification- Amber 2 specialist initiation / recommendation Information

More information

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line)

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) For in vitro diagnostic use. CLIA Complexity for Whole Blood: WAIVED INTENDED USE The QuickVue H. pylori Test is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies

More information

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents For in vitro diagnostic use. CLIA Complexity: MODERATE INTENDED USE The QuickVue H. pylori Test is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies specific to

More information

Collection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA PCR. MOH Regional Trainings March 2013

Collection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA PCR. MOH Regional Trainings March 2013 Collection of Dried Blood Spots from Infants for Diagnosis of HIV by DNA MOH Regional Trainings March 2013 Outline Introduce DBS testing Rationale Testing algorithm Sample collection, storage and transportation

More information

CLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation

CLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation CLIA Complexity for Whole Blood: WAIVED Intended Use The is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies specific to Helicobacter pylori in whole blood. The

More information

Pulmonary Embolism Pathway

Pulmonary Embolism Pathway Pulmonary Embolism Pathway Ambulatory Care Pathway Dr. A. Zafar, Dr. A. Rehman, Dr. T. Malik September, 2011. Patient Identification Label Pulmonary Embolism Pathway Clinical History Comments Hospital

More information

How to prevent blood clots whilst in hospital and after your return home

How to prevent blood clots whilst in hospital and after your return home How to prevent blood clots whilst in hospital and after your return home Patient information WHAT What IS is DEEP deep VEIN vein THROMBOSIS? thrombosis? Deep Vein Thrombosis DVT is a blood clot within

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

Rivaroxaban film coated tablets are available in 2 strengths for this indication: 15mg and 20mg.

Rivaroxaban film coated tablets are available in 2 strengths for this indication: 15mg and 20mg. Primary Care Prescriber Information RIVAROXABAN (XARELTO ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism INDICATION Rivaroxaban is a non-vitamin K antagonist

More information

What is Clexane and what is it used for?

What is Clexane and what is it used for? TO PROVIDE THE VERY BEST CARE FOR EACH PATIENT ON EVERY OCCASION What is Clexane and what is it used for? An information guide What is Clexane and what is it used for? CLEXANE (also known as Enoxaparin)

More information

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism A pulmonary embolism (PE) is

More information

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital

Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital Please Note: This policy is currently under review and is still fit for purpose. Venous Thromboembolism (VTE) Prevention and Treatment of VTE in Patients Admitted to Hospital This procedural document supersedes

More information

ANTIBODY SCREENING by Uni-Gold Recombigen HIV

ANTIBODY SCREENING by Uni-Gold Recombigen HIV ANTI-HIV SPECIMEN 1 REQUIREMENTS ANTIBODY SCREENING by Uni-Gold Recombigen HIV PRINCIPLE: The Uni-Gold Recombigen HIV was designed as a rapid immunoassay and is intended to detect antibodies to HIV- 1

More information

Surgery for Patients on Oral Anticoagulants

Surgery for Patients on Oral Anticoagulants Surgery for Patients on Oral Anticoagulants (for example: warfarin, rivaroxaban, apixaban, dabigatran, edoxaban) Surgery Patient Information Leaflet You have been given this leaflet because you are due

More information

Inhixa (Enoxaparin Sodium)

Inhixa (Enoxaparin Sodium) Inhixa (Enoxaparin Sodium) P R E V ENTIS SAFETY D E V I C E P R E V E N T I S I S A N AU TO M AT I C N E E D L E S H I E L D I N G S Y S T E M, W H I C H H A S A C O V E R T H AT E X T E N D S O V E R

More information

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine Venous thromboembolism: pulmonary embolism (PE) deep vein thrombosis (DVT) 1% of all patients admitted to hospital 5% of in-hospital mortality

More information

Management of Central Venous Access Devices. Blood Glucose Monitoring

Management of Central Venous Access Devices. Blood Glucose Monitoring Management of Central Venous Access Devices Blood Glucose Monitoring Purpose To provide education on the standard of care regarding the use and monitoring of the Accu- Chek Blood glucose machine, including

More information

Primary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism

Primary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism Primary Care Prescriber Information EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism INDICATION Edoxaban is a non-vitamin K antagonist oral

More information

Inferior Vena Cava Filter for DVT

Inferior Vena Cava Filter for DVT Inferior Vena Cava Filter for DVT Deep Vein Thrombosis A deep vein thrombosis (DVT) is a blood clot that forms in a deep vein. This is a serious condition that occurs more often than you might think. If

More information

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast Information for patients Pharmacy Your doctor has prescribed a tablet called rivaroxaban. This leaflet tells you about

More information

FOR INFORMATIONAL USE ONLY

FOR INFORMATIONAL USE ONLY CLIA-WAIVED PROCEDURE FOR WHOLE BLOOD INTENDED USE QuickVue+ Infectious Mononucleosis test is a rapid Color lmmunochromatographic Assay (CICA) for the detection of Infectious Mononucleosis lgm heterophile

More information

GOING IN THE INJECTING THE

GOING IN THE INJECTING THE GOING IN THE INJECTING THE GROIN FEMORAL VEIN The vein in your groin is not like the veins in your arms. People who inject in the groin suffer more serious health problems and some of them die. Why Inject

More information

Accu-Chek Inform II: Point of Care Glucose Testing. Sharp Healthcare 2014

Accu-Chek Inform II: Point of Care Glucose Testing. Sharp Healthcare 2014 Accu-Chek Inform II: Point of Care Glucose Testing Sharp Healthcare 2014 OBJECTIVES At the completion of this module the participant will be able to: Learn the proper technique of performing a finger stick

More information

Title Use and monitoring of Low Molecular Weight Heparins (LMWHs) in community hospitals and community nursing Clinical Guidelines

Title Use and monitoring of Low Molecular Weight Heparins (LMWHs) in community hospitals and community nursing Clinical Guidelines Document Control Title Use and monitoring of Low Molecular Weight Heparins (LMWHs) in community hospitals and community nursing Clinical Guidelines Author Team Directorate Medical Date Version Status Issued

More information

Peripheral Vascular Examination. Dr. Gary Mumaugh Western Physical Assessment

Peripheral Vascular Examination. Dr. Gary Mumaugh Western Physical Assessment Peripheral Vascular Examination Dr. Gary Mumaugh Western Physical Assessment Competencies 1. Inspection of upper extremity for: size symmetry swelling venous pattern color Texture nail beds Competencies

More information

Diagnosis of Venous Thromboembolism

Diagnosis of Venous Thromboembolism Diagnosis of Venous Thromboembolism An Educational Slide Set American Society of Hematology 2018 Guidelines for Management of Venous Thromboembolism Slide set authors: Eric Tseng MD MScCH, University of

More information

DRUG NAME: EDOXABAN (LIXIANA ) Transfer of Care document Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism

DRUG NAME: EDOXABAN (LIXIANA ) Transfer of Care document Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism City and Hackney Clinical Commissioning Group Homerton University Hospital Foundation Trust DRUG NAME: EDOXABAN (LIXIANA ) Treatment of acute venous thromboembolism and prevention of recurrent venous thromboembolism

More information

A A U

A A U PVD Venous AUC Rating Sheet 2nd Round 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Median I NI MADM Rating Agree Disagree Upper Extremity Venous Evaluation Table 1. Venous Duplex of the Upper Extremities for Patency

More information

CoaguChek Outpatient Clinic: CoaguChek XS - Quick Reference Guide

CoaguChek Outpatient Clinic: CoaguChek XS - Quick Reference Guide CoaguChek Outpatient Clinic: CoaguChek XS - Quick Reference Guide CoaguChek XS Quick Reference Guide Page 1 Page 1 of 18 Coaguchek XS Monitor A DISPLAY B - M (memory button) o To recall results from memory

More information

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate

2 Summary of NICE TA 249: Atrial fibrillation - Dabigatran Etexilate Service Notification in response to DHSSPS endorsed NICE Technology Appraisals NICE TA 249: Atrial fibrillation - Dabigatran Etexilate 1 Name of Commissioning Team Long Term Conditions Commissioning Team

More information

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16

pat hways Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 pat hways Anticoagulants, including non-vitamin K antagonist oral anticoagulants (NOACs) Key therapeutic topic Published: 26 February 2016 nice.org.uk/guidance/ktt16 Options for local implementation NICE

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information

Hand & Plastics Physiotherapy Department Extensor Tendon Repair Zone IV and above Information for patients

Hand & Plastics Physiotherapy Department Extensor Tendon Repair Zone IV and above Information for patients Oxford University Hospitals NHS Trust Hand & Plastics Physiotherapy Department Extensor Tendon Repair Zone IV and above Information for patients Introduction You have had surgery to repair one or more

More information

The Leeds Teaching Hospitals NHS Trust Catheter directed thrombolysis and pelvic venous stenting for ilio-femoral DVT

The Leeds Teaching Hospitals NHS Trust Catheter directed thrombolysis and pelvic venous stenting for ilio-femoral DVT n The Leeds Teaching Hospitals NHS Trust Catheter directed thrombolysis and pelvic venous stenting for ilio-femoral DVT Information for patients Catheter directed thrombolysis and pelvic venous stenting

More information

Blood Glucose Monitoring System

Blood Glucose Monitoring System Blood Glucose Monitoring System Self monitoring of blood glucose (SMBG) is an important part of diabetes care, but the high cost of testing can make it difficult. At ACON, our goal is to provide high quality

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

EasyMax Voice III Self-Monitoring Blood Glucose System. Quick Reference Guide

EasyMax Voice III Self-Monitoring Blood Glucose System. Quick Reference Guide EasyMax Voice III Self-Monitoring Blood Glucose System Quick Reference Guide 1 Installing Batteries 1. Open the battery door on the back of the meter by pushing the tab in the direction of the arrow and

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.

More information

Deep Vein Thrombosis and Pulmonary Embolism

Deep Vein Thrombosis and Pulmonary Embolism Page 1 of 12 PATIENT EDUCATION Deep Vein Thrombosis and Pulmonary Embolism Take Steps to Prevent DVTs and PEs Deep vein thrombosis and pulmonary embolism are serious conditions that can affect people of

More information

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients What is a deep vein thrombosis (DVT)? A DVT is a blood clot that forms within a vein deep in the leg but can

More information

HIV Testing in Children

HIV Testing in Children Module 6 HIV Testing in Children Total Module Time: 185 minutes (3 hours, 5 minutes) Learning Objectives After completing this module, participants will be able to: Understand the procedure for collecting

More information

This information is intended as a general guide only. Please ask if you have any questions relating to this information.

This information is intended as a general guide only. Please ask if you have any questions relating to this information. Foam Sclerotherapy (Varicose vein injections) Vascular Surgery This information is intended as a general guide only. Please ask if you have any questions relating to this information. Varicose Veins Veins

More information

Tips for Training New Customers

Tips for Training New Customers Tips for Training New Customers Good Habits: Test Strips Recap vial immediately and tightly after removing a single test strip. Never remove the desiccant from the vial. Do not lay test strips out ahead

More information

Ultrasound guided neck lump biopsy

Ultrasound guided neck lump biopsy Ultrasound guided neck lump biopsy Information for patients Diagnostic Imaging Department X-Ray and Scanning Specialist Support If you require this leaflet in another language, large print or another format,

More information

Venous Thromboembolic Events (VTEs)

Venous Thromboembolic Events (VTEs) Venous Thromboembolic Events (VTEs) This Infosheet explains what a VTE is, what the causes and risk factors for VTEs are, the symptoms of a VTE, how they can be treated and some tips for self-management.

More information